Additionally, DPP-4i restricted diabetes-associated cognitive deficits by modulating neuroinflammatory indicators of caveolin 1 (Cav 1) and brain-derived neurotrophic factor (BDNF), thus reducing inflammatory response in the brain [56]. This evidence concerns the gene BDNF and Cognitive impairment.